Sign Up to like & get
recommendations!
0
Published in 2020 at "American journal of clinical pathology"
DOI: 10.1093/ajcp/aqaa007
Abstract: OBJECTIVES To improve diagnostic accuracy in differentiating hematogones from leukemic blasts in cases of precursor B-lymphoblastic leukemia/lymphoma (B-ALL), particularly those that are posttreatment or after bone marrow transplant, and to provide an algorithmic approach to…
read more here.
Keywords:
lymphoblastic leukemia;
precursor lymphoblastic;
cd81;
cd58 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Cancer research"
DOI: 10.1158/0008-5472.can-23-2874
Abstract: Recurrent abnormalities in immune surveillance-related genes affect the progression of diffuse large B-cell lymphoma (DLBCL) and modulate the response to therapeutic interventions. CD58 interacts with the CD2 receptor on T cells and natural killer (NK)…
read more here.
Keywords:
cd58;
dlbcl;
cell lymphoma;
cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.7057
Abstract: 7057 Background: Recurrent abnormalities of immune surveillance-related genes play a crucial role in DLBCL progression. Prior studies have shown that CD58, a key adhesion molecule that acts as a ligand for the T-cell costimulatory molecule…
read more here.
Keywords:
cd58;
dlbcl;
therapy;
role ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.16029
Abstract: Abstract Background/Aim: CD58 is an immune adhesion molecule on the cellular surface. It was previously found that a high expression of CD58 predicted a poor prognosis of patients with lower-grade gliomas. Therefore, the aim of…
read more here.
Keywords:
basal like;
cd58;
expression;
breast cancer ... See more keywords